tunnelvisionofplenty
5 minutes ago
Awesome news! With this, the approval rate for new non-IRP medicines in my sample is up to 91.3%; of 24 candidates, 21 have now been approved, 2 have not been approved, and 1 is pending (DCVax-L).
This single data point gives me a huge amount of confidence in approval. Simply put, med